Aller au contenu principal
Retour à l'annuaire
RhumatologueMédecins généralistes et spécialistes⚖️ Libéral activité salarié

M. Docteur Andre COHEN

📍 Nice (06)Libéral💶 Secteur 1RPPS 10003276317
📕 1 livre

✨ Profil synthétique

IA · 29/04/2026

Le Docteur Andre COHEN est un rhumatologue libéral exerçant à Nice. Ses publications sur PubMed couvrent divers aspects de la rhumatologie, notamment l'épidémiologie, la génétique et les pathologies spécifiques comme la goutte et l'ostéoporose. Il s'intéresse également à l'analyse de données issues de la vie réelle (RWE).

Expertises présumées

  • Goutte
  • Ostéoporose
  • Épidémiologie en rhumatologie
  • Génétique des maladies rhumatismales
  • Recherche en vie réelle (RWE)
  • Registres de maladies rhumatismales
  • Analyse des données de santé

Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.

Diplômes

🎓 DES & spécialité ordinale

  • Rhumatologie (SM)

📚 CES (Certificat d'Études Spéciales)

  • CES Rhumatologie

🎓 Diplômes

  • DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Livres & ouvrages

Source : Google Books — filtre catégories médicales/santé/sciences.

Localisation des cabinets

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieux de consultation

Tarifs & secteur de conventionnement

🟢 Secteur 1 — Tarif conventionnéSource CNAM (Annuaire santé Ameli)
💳 Carte VitaleLibéral activité salarié

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

  • 1
    Genetic correlates of vitamin D-binding protein and 25-hydroxyvitamin D in neonatal dried blood spots

    Nature communications · 2023

    📚 27 citations🎯 RCR 3.31Top 14% NIH🔓 Open Access📄 PDF gratuit ↗
    Lire l'abstract Crossref ↓

    Abstract The vitamin D binding protein (DBP), encoded by the group-specific component ( GC ) gene, is a component of the vitamin D system. In a genome-wide association study of DBP concentration in 65,589 neonates we identify 26 independent loci, 17 of which are in or close to the GC gene, with fine-mapping identifying 2 missense variants on chromosomes 12 and 17 (within SH2B3 and GSDMA , respectively). When adjusted for GC haplotypes, we find 15 independent loci distributed over 10 chromosomes. Mendelian randomization analyses identify a unidirectional effect of higher DBP concentration and (a) higher 25-hydroxyvitamin D concentration, and (b) a reduced risk of multiple sclerosis and rheumatoid arthritis. A phenome-wide association study confirms that higher DBP concentration is associated with a reduced risk of vitamin D deficiency. Our findings provide valuable insights into the influence of DBP on vitamin D status and a range of health outcomes.

  • 2
    Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023

    📚 23 citations🎯 RCR 4.42Top 9% NIH
  • 3
    COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry

    Kidney360 · 2023

    📚 17 citations🎯 RCR 2.14Top 25% NIH🔓 Open Access
    Lire l'abstract Crossref ↓

    Key Points IgAN and MCD are the most common de novo glomerular diseases reported after COVID-19 vaccination, particularly after mRNA vaccination.Membranous nephropathy, pauci-immune GN, and collapsing GN have also been attributed to COVID-19 vaccination, some with dual histologies.Recovery of kidney function and proteinuria remission is more likely in IgAN and MCD by 4–6 months compared with the other glomerular diseases. Background Patients with de novo glomerular disease (GD) with various renal histologies have been reported after vaccination against SARS-CoV-2. Causality has not been established, and the long-term outcomes are not known. To better characterize the GDs and clinical courses/outcomes, we created the International Registry of COVID-19 vaccination and Glomerulonephritis to study in aggregate patients with de novo GN suspected after COVID-19 vaccine exposure. Methods A REDCap survey was used for anonymized data collection. Detailed information on vaccination type and timing and GD histology were recorded in the registry. We collected serial information on laboratory values (before and after vaccination and during follow-up), treatments, and kidney-related outcomes. Results Ninety-eight patients with GD were entered into the registry over 11 months from 44 centers throughout the world. Median follow-up was 89 days after diagnosis. IgA nephropathy (IgAN) and minimal change disease (MCD) were the most common kidney diseases reported. Recovery of kidney function and remission of proteinuria were more likely in IgAN and MCD at 4–6 months than with pauci-immune GN/vasculitis and membranous nephropathy. Conclusions The development of GD after vaccination against SARS-CoV-2 may be a very rare adverse event. Temporal association is present for IgAN and MCD, but causality is not firmly established. Kidney outcomes for IgAN and MCD are favorable. No changes in vaccination risk-benefit assessment are recommended based on these findings.

Publications scientifiques (50) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal23

Épidémiologie & registres6

Génétique3

Revue générale3

Goutte2

Ostéoporose2

Vraie vie / RWE2

Anti-IL-171

Case report / série1

Corticothérapie1

Essai clinique1

Lupus1

Maladie de Horton1

Revue / méta-analyse1

Risque cardio-vasculaire1

SAPL1

Vascularites1

Vascularites des gros vaisseaux1

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.